• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT MITRACLIP SYSTEM CLIP DELIVERY SYSTEM NT; MITRACLIP DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT MITRACLIP SYSTEM CLIP DELIVERY SYSTEM NT; MITRACLIP DELIVERY SYSTEM Back to Search Results
Catalog Number CDS0502
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Endocarditis (1834); Unspecified Infection (1930); Mitral Regurgitation (1964); Nausea (1970)
Event Date 05/29/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The clip remains in the patient.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.The additional mitraclip device referenced is being filed under a separate medwatch report.
 
Event Description
This is filed to report endocarditis and increased mitral regurgitation (mr).It was reported that the initial mitraclip procedure was performed on (b)(6) 2019 to treat functional mr with a grade of 4.Two clips were implanted reducing mr to 1.On (b)(6) 2019, the patient reported nausea due to ileus (stomach ache).The patient was re-admitted.On (b)(6) 2019, vegetation on the valve was noted, but overlooked as it was small.C-reactive protein (crp) value was increasing to about 4, blood culture was examined.Examination revealed the patient had infective endocarditis with (b)(6).On (b)(6) 2019, it was confirmed that the clips were stable, but vegetation was greater between the two clips and mr increased to 3.The patient is on antibiotic treatment.On (b)(6) 2019, the patient remains on antibiotics as (b)(6) and size of vegetation has not changed.A transesophageal echocardiography (tee) is scheduled for a later date.No additional information was provided.
 
Manufacturer Narrative
Internal file: (b)(4).Patient identifier added.The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents reported from this lot.The investigation determined the reported patient effects of infection, recurrent mitral regurgitation and nausea appears to be related to the endocarditis.However, a conclusive cause for the endocarditis cannot be determined.The reported patient effects of endocarditis, infection, recurrent mr and nausea, as listed in the mitraclip system instructions for use, are known possible complications associated with mitraclip procedures.There is no indication of a product issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP SYSTEM CLIP DELIVERY SYSTEM NT
Type of Device
MITRACLIP DELIVERY SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 4628
MDR Report Key8731423
MDR Text Key149095005
Report Number2024168-2019-05051
Device Sequence Number1
Product Code NKM
Combination Product (y/n)N
PMA/PMN Number
P100009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Remedial Action Other
Type of Report Initial,Followup
Report Date 09/26/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date09/15/2019
Device Catalogue NumberCDS0502
Device Lot Number80914U124
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 06/05/2019
Initial Date FDA Received06/25/2019
Supplement Dates Manufacturer Received09/11/2019
Supplement Dates FDA Received09/26/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age75 YR
-
-